Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

OPRK1 anticorps (AA 31-50) (FITC)

L’anticorps Lapin Polyclonal anti-OPRK1 a été validé pour . Il convient pour détecter OPRK1 dans des échantillons de Humain.
N° du produit ABIN7139901

Aperçu rapide pour OPRK1 anticorps (AA 31-50) (FITC) (ABIN7139901)

Antigène

Voir toutes OPRK1 Anticorps
OPRK1 (Opioid Receptor, kappa 1 (OPRK1))

Reactivité

  • 48
  • 45
  • 39
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 61
  • 2
  • 1
Lapin

Clonalité

  • 63
  • 1
Polyclonal

Conjugué

  • 31
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp OPRK1 est conjugé à/à la FITC

Application

Veuillez nous consulter SVP
  • Épitope

    • 11
    • 7
    • 7
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 31-50

    Fonction

    OPRK1 Antibody, FITC conjugated

    Purification

    Antigen Affinity Purified

    Immunogène

    Peptide sequence from Human Kappa-type opioid receptor protein (31-50AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    OPRK1 (Opioid Receptor, kappa 1 (OPRK1))

    Autre désignation

    OPRK1

    Sujet

    Background: G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions.

    Aliases: K-OR-1 antibody, Kappa opioid receptor antibody, Kappa type opioid receptor antibody, Kappa-type opioid receptor antibody, KOR 1 antibody, KOR antibody, KOR-1 antibody, Opiate receptor kappa 1 antibody, Opiate receptor, kappa 1 antibody, Opioid receptor, kappa 1 antibody, OPRK 1 antibody, OPRK antibody, OPRK_HUMAN antibody, OPRK1 antibody, Oprk2 antibody, R21 antibody

    UniProt

    P41145
Vous êtes ici:
Chat with us!